Poster Presentation: Remimazolam A Retrospective Study of Initial Safety and Efficacy Data in Diverse Procedural Sedation

Availability

On-Demand

Expires on 02/20/2025

Cost

$0.00

Credit Offered

0.25 Class A Credit

0.25 Pharmacology Credit

Limited literature existed beyond pharmaceutical sponsorship utilizing remimazolam in procedural settings and consist of fixed dosing based on the American Society of Anesthesiologists physical status score (ASA-PS). Increasing patient acuity in outpatient setting demands utilizing drugs in which minimize hemodynamic and respiratory impact. Conventional sedative medications create drawbacks in clinical practices that impact patient outcomes, length of recovery, and the efficiency of procedural workflows, leading to potential increase in costs and resource utilization.

Examine real-world utilization of remimazolam in diverse procedural and patient populations to support the development of a nurse sedation protocol with remimazolam and fentanyl utilizing a non-ASA-PS dosing strategy. 

Learning Outcomes:

Identify factors that influence the time it takes for patients to become alert after sedation with Remimazolam.

Define breakpoints in dose-response for appropriate dosing strategies by ASA-PS

This program has been prior approved by the American Association of Nurse Anesthesiology for 0.25 Class A CE credits; Code Number 1044773; Expiration Date 2/20/2025.

AANA designates this program as meeting the criteria for up to 0.25 CE Credits in pharmacology/therapeutics.

Kelsey Johnson, RN

Accreditation Information:
The American Association of Nurse Anesthesiology is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

AANA is an approved provider by the California Board of Registered Nursing, CEP #10862.

Disclosure Statement:
Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content will be identified by the Nurse Planner within the activity. Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content has been mitigated.

Post-Test Attempt Notice:
A minimum passing score of 80% is required to pass this course. You have TWO opportunities to achieve a passing score. If you fail to achieve a passing score of 80%, you will not receive CE credit for this course.

Content Disclaimer:
The views, information, or opinions expressed within the videos and audio are solely those of the individuals involved and do not necessarily represent those of the American Association of Nurse Anesthesiology.

Course content has been prepared by the presenter/developer, and each viewer agrees that the presenter/developer is solely responsible for the content and the accuracy thereof. The viewer agrees that the American Association of Nurse Anesthesiology has no responsibility or liability for the accuracy or completeness of the content.

Refund Policy:
Continuing education activities are nonrefundable.